Ovation Science Inc. (OVATF)
OTCMKTS
· Delayed Price · Currency is USD
0.0485
0.00 (0.00%)
At close: May 20, 2025
Ovation Science Revenue
In the year 2024, Ovation Science had annual revenue of 113.22K CAD with 82.80% growth. Ovation Science had revenue of 16.09K in the quarter ending December 31, 2024, with 8.56% growth.
Revenue
113.22K CAD
Revenue Growth
+82.80%
P/S Ratio
9.73
Revenue / Employee
n/a
Employees
n/a
Market Cap
765.32K USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
BioStem Technologies | 332.45M |
Ovation Science News
- 6 months ago - Ovation Science Licensee Launches Innovative Transdermal Cannabis Products in Pennsylvania - Accesswire
- 1 year ago - Ovation Science Topicals Launch with Planet 13 in Nevada - Accesswire
- 1 year ago - Planet 13 Launches New MEDIZIN Branded Topicals - Introducing MEDIZIN Rest, Recovery and Relief - Accesswire
- 1 year ago - Ovation Science Expands Market Reach with Exclusive Canadian License Agreement - Accesswire
- 1 year ago - Ovation Science Announces License Agreement for Its Topical / Transdermal Cannabis Products for Missouri - PRNewsWire
- 1 year ago - Ovation Science Signs License Agreement with Planet 13 for Its Topical / Transdermal Cannabis Products for Nevada - PRNewsWire
- 2 years ago - Ovation Science Signs Exclusive License Agreement for Its Topical / Transdermal Cannabis Products for Pennsylvania - PRNewsWire
- 2 years ago - Ovation Science Announces International Supply and Distribution Agreement - PRNewsWire